Literature DB >> 21652123

Conformational study on cyclic melanocortin ligands and new insight into their binding mode at the MC4 receptor.

Paolo Grieco1, Diego Brancaccio, Ettore Novellino, Victor J Hruby, Alfonso Carotenuto.   

Abstract

The melanocortin receptors are involved in many physiological functions, including pigmentation, sexual function, feeding behavior, and energy homeostasis, making them potential targets to treat obesity, sexual dysfunction, etc. Understanding the basis of the ligand-receptor interactions is crucial for the design of potent and selective ligands for these receptors. The conformational preferences of the cyclic melanocortin ligands MTII (Ac-Nle(4)-c[Asp(5)-His(6)-DPhe(7)-Arg(8)-Trp(9)-Lys(10)]-NH(2)) and SHU9119 (Ac-Nle(4)-c[Asp(5)-His(6)-DNal(2')(7)-Arg(8)-Trp(9)-Lys(10)]-NH(2)), which show agonist and antagonist activity at the h-MC4R, respectively, were comprehensively investigated by solution NMR spectroscopy in different environments. In particular, water and water/DMSO (8:2) solutions were used as isotropic solutions and an aqueous solution of DPC (dodecylphosphocholine) micelles was used as a membrane mimetic environment. NMR-derived conformations of these two ligands were docked within h-MC4R models. NMR and docking studies revealed intriguing differences which can help explain the different activities of these two ligands.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21652123      PMCID: PMC5102844          DOI: 10.1016/j.ejmech.2011.05.038

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  74 in total

1.  Optimization of privileged structures for selective and potent melanocortin subtype-4 receptor ligands.

Authors:  Qingmei Hong; Raman K Bakshi; James Dellureficio; Shuwen He; Zhixiong Ye; Peter H Dobbelaar; Iyassu K Sebhat; Liangqin Guo; Jian Liu; Tianying Jian; Rui Tang; Rubana N Kalyani; Tanya Macneil; Aurawan Vongs; Charles I Rosenblum; David H Weinberg; Qingping Peng; Constantin Tamvakopoulos; Randy R Miller; Ralph A Stearns; Doreen Cashen; Willian J Martin; Airu S Chen; Joseph M Metzger; Howard Y Chen; Allison M Strack; Tung M Fong; Euan Maclntyre; Lex H T Van der Ploeg; Matthew J Wyvratt; Ravi P Nargund
Journal:  Bioorg Med Chem Lett       Date:  2010-06-10       Impact factor: 2.823

2.  The program XEASY for computer-supported NMR spectral analysis of biological macromolecules.

Authors:  C Bartels; T H Xia; M Billeter; P Güntert; K Wüthrich
Journal:  J Biomol NMR       Date:  1995-07       Impact factor: 2.835

3.  Molecular pharmacology of neural melanocortin receptors.

Authors:  R A Adan; J Oosterom; R F Toonen; M V Kraan; J P Burbach; W H Gispen
Journal:  Receptors Channels       Date:  1997

4.  Torsion angle dynamics for NMR structure calculation with the new program DYANA.

Authors:  P Güntert; C Mumenthaler; K Wüthrich
Journal:  J Mol Biol       Date:  1997-10-17       Impact factor: 5.469

5.  Mutations in the human melanocortin-4 receptor gene associated with severe familial obesity disrupts receptor function through multiple molecular mechanisms.

Authors:  Giles S H Yeo; Emma J Lank; I Sadaf Farooqi; Julia Keogh; Benjamin G Challis; Stephen O'Rahilly
Journal:  Hum Mol Genet       Date:  2003-03-01       Impact factor: 6.150

6.  Effect of an alpha-melanocyte stimulating hormone analog on penile erection and sexual desire in men with organic erectile dysfunction.

Authors:  H Wessells; D Gralnek; R Dorr; V J Hruby; M E Hadley; N Levine
Journal:  Urology       Date:  2000-10-01       Impact factor: 2.649

Review 7.  Pro-opiomelanocortin processing in the hypothalamus: impact on melanocortin signalling and obesity.

Authors:  L E Pritchard; A V Turnbull; A White
Journal:  J Endocrinol       Date:  2002-03       Impact factor: 4.286

8.  Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor.

Authors:  D Lu; D Willard; I R Patel; S Kadwell; L Overton; T Kost; M Luther; W Chen; R P Woychik; W O Wilkison
Journal:  Nature       Date:  1994-10-27       Impact factor: 49.962

9.  Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain.

Authors:  K G Mountjoy; M T Mortrud; M J Low; R B Simerly; R D Cone
Journal:  Mol Endocrinol       Date:  1994-10

10.  4-Norleucine, 7-D-phenylalanine-alpha-melanocyte-stimulating hormone: a highly potent alpha-melanotropin with ultralong biological activity.

Authors:  T K Sawyer; P J Sanfilippo; V J Hruby; M H Engel; C B Heward; J B Burnett; M E Hadley
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

View more
  5 in total

1.  The role of common and rare MC4R variants and FTO polymorphisms in extreme form of obesity.

Authors:  Vita Rovite; Ramona Petrovska; Iveta Vaivade; Ineta Kalnina; Davids Fridmanis; Linda Zaharenko; Raitis Peculis; Valdis Pirags; Helgi B Schioth; Janis Klovins
Journal:  Mol Biol Rep       Date:  2014-01-03       Impact factor: 2.316

2.  Development of Macrocyclic Peptidomimetics Containing Constrained α,α-Dialkylated Amino Acids with Potent and Selective Activity at Human Melanocortin Receptors.

Authors:  Francesco Merlino; Yang Zhou; Minying Cai; Alfonso Carotenuto; Ali M Yousif; Diego Brancaccio; Salvatore Di Maro; Silvia Zappavigna; Antonio Limatola; Ettore Novellino; Paolo Grieco; Victor J Hruby
Journal:  J Med Chem       Date:  2018-04-25       Impact factor: 7.446

3.  Azepinone-Containing Tetrapeptide Analogues of Melanotropin Lead to Selective hMC4R Agonists and hMC5R Antagonist.

Authors:  Olivier Van der Poorten; Krisztina Fehér; Koen Buysse; Debby Feytens; Ioanna Zoi; Steven D Schwartz; José C Martins; Dirk Tourwé; Minying Cai; Victor J Hruby; Steven Ballet
Journal:  ACS Med Chem Lett       Date:  2014-12-03       Impact factor: 4.345

4.  Discovery of Novel Potent and Selective Agonists at the Melanocortin-3 Receptor.

Authors:  Alfonso Carotenuto; Francesco Merlino; Minying Cai; Diego Brancaccio; Ali Munaim Yousif; Ettore Novellino; Victor J Hruby; Paolo Grieco
Journal:  J Med Chem       Date:  2015-12-16       Impact factor: 7.446

5.  DOTA-Derivatives of Octreotide Dicarba-Analogs with High Affinity for Somatostatin sst2,5 Receptors.

Authors:  Alessandro Pratesi; Mauro Ginanneschi; Marco Lumini; Anna M Papini; Ettore Novellino; Diego Brancaccio; Alfonso Carotenuto
Journal:  Front Chem       Date:  2017-02-23       Impact factor: 5.221

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.